Clinical trial
Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children…
NCT00004068 · St. Jude Children's Research Hospital, Other · Completed
Key facts
| NCT number | NCT00004068 |
|---|---|
| Title | Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor |
| Official title | Treatment of Newly Diagnosed High-Grade Gliomas in Patients Ages Greater Than or Equal to 3 and Less Than or Equal to 21 Years With a Phase II Irinotecan Window Followed by Radiation Therapy and Temozolomide |
| Lead sponsor | St. Jude Children's Research Hospital, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | irinotecan hydrochloride, temozolomide, conventional surgery, radiation therapy |
| Enrollment | 53 |
| Start date | Mar 1, 1999 |
| Primary completion | Apr 1, 2003 |
| Completion | Apr 1, 2003 |
| First posted | May 8, 2003 |
| Last update posted | Oct 4, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: